1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Molecular Quality Controls Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Molecular Quality Controls Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rise in funding by the manufacturers and governments in the field of genomics is supporting the growth of the molecular quality controls market
5.2 Market Opportunities
- 5.2.1 Increasing focus on molecular diagnostics is emerging as a key opportunity for the molecular quality controls market players
5.3 Future Trends
- 5.3.1 Growing adoption of personalized medicines based on patient
5.4 Impact of Drivers and Restraints
6. Europe Molecular Quality Controls Market Regional Analysis
6.1 Europe Molecular Quality Controls Market Overview
6.2 Europe Molecular Quality Controls Market Revenue 2019-2028 (US$ Million)
6.3 Europe Molecular Quality Controls Market Forecast Analysis
7. Europe Molecular Quality Controls Market Analysis – by Product
7.1 Independent Controls
- 7.1.1 Overview
- 7.1.2 Independent Controls: Europe Molecular Quality Controls Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Instrument Specific Controls
- 7.2.1 Overview
- 7.2.2 Instrument Specific Controls: Europe Molecular Quality Controls Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Molecular Quality Controls Market Analysis – by Analyte Type
8.1 Single Analyte Controls
- 8.1.1 Overview
- 8.1.2 Single Analyte Controls: Europe Molecular Quality Controls Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Multi Analyte Controls
- 8.2.1 Overview
- 8.2.2 Multi Analyte Controls: Europe Molecular Quality Controls Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Molecular Quality Controls Market Analysis – by Application
9.1 Infectious Diseases
- 9.1.1 Overview
- 9.1.2 Multi Analyte Controls: Europe Molecular Quality Controls Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Oncology
- 9.2.1 Overview
- 9.2.2 Multi Analyte Controls: Europe Molecular Quality Controls Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Genetic Testing
- 9.3.1 Overview
- 9.3.2 Multi Analyte Controls: Europe Molecular Quality Controls Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Other Applications
- 9.4.1 Overview
- 9.4.2 Multi Analyte Controls: Europe Molecular Quality Controls Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Molecular Quality Controls Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Molecular Quality Controls Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.1.1.1 Europe Molecular Quality Controls Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Molecular Quality Controls Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 UK: Europe Molecular Quality Controls Market Breakdown, by Product
- 10.1.1.1.2 UK: Europe Molecular Quality Controls Market Breakdown, by Analyte Type
- 10.1.1.1.3 UK: Europe Molecular Quality Controls Market Breakdown, by Application
- 10.1.1.2 Germany:
Europe Molecular Quality Controls Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Germany: Europe Molecular Quality Controls Market Breakdown, by Product
- 10.1.1.2.2 Germany: Europe Molecular Quality Controls Market Breakdown, by Analyte Type
- 10.1.1.2.3 Germany: Europe Molecular Quality Controls Market Breakdown, by Application
- 10.1.1.3 France:
Europe Molecular Quality Controls Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 France: Europe Molecular Quality Controls Market Breakdown, by Product
- 10.1.1.3.2 France: Europe Molecular Quality Controls Market Breakdown, by Analyte Type
- 10.1.1.3.3 France: Europe Molecular Quality Controls Market Breakdown, by Application
- 10.1.1.4 Russia:
Europe Molecular Quality Controls Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.1 Russia: Europe Molecular Quality Controls Market Breakdown, by Product
- 10.1.1.4.2 Russia: Europe Molecular Quality Controls Market Breakdown, by Analyte Type
- 10.1.1.4.3 Russia: Europe Molecular Quality Controls Market Breakdown, by Application
- 10.1.1.5 Italy:
Europe Molecular Quality Controls Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.1 Italy: Europe Molecular Quality Controls Market Breakdown, by Product
- 10.1.1.5.2 Italy: Europe Molecular Quality Controls Market Breakdown, by Analyte Type
- 10.1.1.5.3 Italy: Europe Molecular Quality Controls Market Breakdown, by Application
- 10.1.1.6 Rest of Europe:
Europe Molecular Quality Controls Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Molecular Quality Controls Market Breakdown, by Product
- 10.1.1.6.2 Rest of Europe: Europe Molecular Quality Controls Market Breakdown, by Analyte Type
- 10.1.1.6.3 Rest of Europe: Europe Molecular Quality Controls Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Molecular Quality Controls Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 BIO-RAD LABORATORIES INC.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 HOFFMANN-LA ROCHE LTD.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Abbott
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Quidel Corporation
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Qnostics
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Maine Molecular Quality Controls Inc.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Zeptometrix Corporation
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Microbiologics
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Seracare Life Sciences
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights